Abstract

Dermatologists are well aware of the potential risks to a fetus exposed to oral isotretinoin during the first trimester of pregnancy. Because of these risks, many clinicians have been concerned about the use of topical tretinoin during pregnancy. In a restrospective review, these authors compared the rates of birth defects among infants of …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call